This company has been marked as potentially delisted and may not be actively trading. Odonate Therapeutics (ODT) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Odonate Inc ODTCJuly 28, 2024 | morningstar.comProQR Therapeutics NV (PRQR)February 6, 2024 | investing.comOrally Disintegrating Tablet (ODT) Market 2023 | Future Exploration by 2030March 29, 2023 | marketwatch.comPfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packagingMarch 19, 2023 | usatoday.comFate Therapeutics Stock (NASDAQ:FATE), Analyst Ratings, Price Targets, PredictionsMarch 3, 2023 | benzinga.comOrally Disintegrating Tablet (ODT) Market Size 2023 with Big Company Segment, Cost-Effective Solutions Analysis Information 2029January 31, 2023 | marketwatch.comODTC Odonate Therapeutics, Inc.October 22, 2022 | seekingalpha.comOdonate TherapeuticsSeptember 14, 2022 | forbes.comODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics, Inc. - ODTDecember 10, 2021 | finance.yahoo.comOdonate Therapeutics Insider Sold Over $2.5M In Company StockNovember 22, 2021 | finance.yahoo.comOdonate Therapeutics, Inc. (ODT)October 27, 2021 | uk.finance.yahoo.comOne Odonate Therapeutics, Inc. (NASDAQ:ODT) insider upped their stake in the previous yearSeptember 27, 2021 | nasdaq.comSHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the FirmSeptember 8, 2021 | finance.yahoo.comA Odonate Therapeutics, Inc. (NASDAQ:ODT) insider increased their holdings last yearSeptember 6, 2021 | finance.yahoo.comOdonate Therapeutics Inc.August 26, 2021 | barrons.comODONATE INVESTIGATION INITIATED by Former...August 21, 2021 | benzinga.comUpdate in Lawsuit for Investors in Odonate Therapeutics, Inc. (NASDAQ:ODT) Announced by Shareholders FoundationAugust 17, 2021 | finance.yahoo.comKaskela Law LLC Announces Stockholder Investigation of Odonate Therapeutics, Inc. - ODTAugust 16, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to InvestorsAugust 13, 2021 | finance.yahoo.comNASDAQ: ODT Investor Notice: Update in Lawsuit against Odonate Therapeutics, Inc. announced by Shareholders FoundationAugust 10, 2021 | benzinga.comThe Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of InvestorsAugust 7, 2021 | finance.yahoo.comOdonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021July 27, 2021 | finance.yahoo.com Get Odonate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ODT and its competitors with MarketBeat's FREE daily newsletter. Email Address ODT Media Mentions By Week ODT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ODT News Sentiment▼0.000.57▲Average Medical News Sentiment ODT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ODT Articles This Week▼00▲ODT Articles Average Week Get Odonate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ODT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Clever Leaves News Neonc Technologies News Seelos Therapeutics News Eli Lilly and Company News Johnson & Johnson News AbbVie News Novo Nordisk A/S News Novartis News Abbott Laboratories News AstraZeneca News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ODT) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Odonate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Odonate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ODT Stock Free ODT Stock Alerts